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Abstract
Background: With ambitious targets to eliminate lymphatic filariasis over the coming years, there is a need to
identify optimal strategies to achieve them in areas with different baseline prevalence and stages of control.
Modelling can assist in identifying what data should be collected and what strategies are best for which scenarios.
Methods: We develop a new individual-based, stochastic mathematical model of the transmission of lymphatic
filariasis. We validate the model by fitting to a first time point and predicting future timepoints from surveillance
data in Kenya and Sri Lanka, which have different vectors and different stages of the control programme. We then
simulate different treatment scenarios in low, medium and high transmission settings, comparing once yearly mass
drug administration (MDA) with more frequent MDA and higher coverage. We investigate the potential impact that
vector control, systematic non-compliance and different levels of aggregation have on the dynamics of
transmission and control.
Results: In all settings, increasing coverage from 65 to 80 % has a similar impact on control to treating twice a year
at 65 % coverage, for fewer drug treatments being distributed. Vector control has a large impact, even at moderate
levels. The extent of aggregation of parasite loads amongst a small portion of the population, which has been
estimated to be highly variable in different settings, can undermine the success of a programme, particularly if high
risk sub-communities are not accessing interventions.
Conclusion: Even moderate levels of vector control have a large impact both on the reduction in prevalence and
the maintenance of gains made during MDA, even when parasite loads are highly aggregated, and use of vector
control is at moderate levels. For the same prevalence, differences in aggregation and adherence can result in very
different dynamics. The novel analysis of a small amount of surveillance data and resulting simulations highlight the
need for more individual level data to be analysed to effectively tailor programmes in the drive for elimination.
Background
Lymphatic filariasis (LF) is one of the neglected tropical
diseases (NTDs) targeted for local and global elimination
as a public health problem within the next decade. The
disease is caused by one of a group a mosquito-borne
filarial nematodes (Wuchereria bancrofti (responsible for
90 % of cases), Brugia malayi or Brugia timori) and can
lead to chronic morbidity, such as lymphedema, which
is associated with pain, severe disability and resulting so-
cial stigmatisation.
It has been estimated that 1.24 billion people are at
risk of LF in tropical and sub-tropical countries in
Africa, Asia, the Western Pacific, the Caribbean and
South America [1, 2]. In response to the large scale
prevalence internationally and the potential to eradicate,
the WHO launched the Global Programme to Eliminate
Lymphatic Filariasis (GPELF) in 2000. The current aim
of GPELF is to use mass drug administration (MDA)
with a combination of donated drugs to reduce and
eventually break transmission. In areas co-endemic with
onchocerciasis, the combination of drugs used in MDA
are ivermectin and albendazole (ALB), whereas diethyl-
carbamazine (DEC) and ALB are used in other endemic
regions. The current strategy is to have yearly treatment
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at 65 % coverage for at least 5 years, followed by regular
transmission assessments to identify whether transmis-
sion has been broken. Initiation of MDA programmes
will be accompanied by morbidity management. The
World Health Organisation has set the target of elimin-
ating lymphatic filariasis as a public health problem glo-
bally by 2020 [3]. A number of countries have reached
the targets of transmission interruption or MDA termin-
ation and others have scaled up their treatment pro-
grammes and are getting close to these targets, reducing
the risk of infection for hundreds of millions of people.
However, there are still large numbers of affected popu-
lations who are unlikely to receive the minimum 5
rounds of treatment by 2020. For these countries the
most effective way to meet the target, if it can be met, is
still open to discussion. Alternate strategies include (i)
MDA at high coverage, (ii) adding moderate vector con-
trol or (iii) twice-yearly treatment.
Mathematical modelling has played a part in under-
standing the transmission dynamics of lymphatic filaria-
sis for many decades (see review by Stolk et al. [4]).
These models have shown that both reductions in mos-
quito biting rates and MDA have the potential to reduce
and even break transmission of LF, but have also
highlighted the importance of ensuring transmission has
truly been broken and maintaining vector control to
prevent bounce-back of infection. There have been some
estimates of the number of rounds of treatment required
to break transmission, for example, Stolk et al. [5] sug-
gest MDA programmes may be required for more years
in Africa than in India due to the higher efficacy of DEC
+ ALB. They also highlighted that increasing coverage is
likely to be an equally effective strategy than treating
twice a year, with the suitability of each depending on
local implementation costs [5]. There has also been
some discussion of the importance of parameter uncer-
tainty, for example Gambhir et al. [6] focused on the im-
portance of such uncertainty on the predictions of
breakpoints (threshold parasite densities at which trans-
mission cannot be maintained). The two main models,
EPIFIL [7], a deterministic model, and LYMFASIM [8],
an individual based model, have been fitted to a limited
number of datasets, primarly the Pondicherry study
[5, 6, 9, 10] and cross-sectional data, such as that
from Tanzania and Kenya [9]. Different modelling pa-
pers give very different estimates of the number of
rounds required to achieve elimination in different
settings, with few papers giving a systematic overview
of the drivers for these differences, and very few models
validated against surveillance data from multiple settings
[4]. There is also a need to validate models against surveil-
lance data and combine it with coverage data in order to
make projections to help programmes in breaking trans-
mission [11].
Here we develop a closely related model to both EPI-
FIL and LYMFASIM, but fit and validate it against re-
cent individual-level surveillance datasets for two quite
different MDA programmes in Kenya and Sri Lanka. We
then simulate the model across a range of different set-
tings to see how yearly MDA compares with (i) MDA at
high coverage, (ii) adding moderate vector control or
with (iii) twice-yearly treatment in order to study how
these affect the probability of elimination after 5 years.
We investigate the role of the main transmitting vector,
the level of aggregation of worms amongst people in the
population and patterns of non-compliance with the
treatment programme on these results. The aim of the
analysis is to understand how simulation outcomes are
dependent on factors associated with setting. They also
will identify the extent to which control programmes
need to be informed by local epidemiological data, such
as prevalence and the level of aggregation of worms, or
the likely coverage of treatment and vector control
programmes.
Methods
Model
We introduce a novel model of filariasis infection in
humans, which can broadly be described as a stochastic
equivalent to the deterministic EPIFIL model without
immunity. A full model description is given in the
Additional files, however we shall briefly give a summary
of the model development here. The model is a stochas-
tic micro-simulation of individuals with worm burden,
microfilaraemia and other demographic parameters re-
lating to age and risk of exposure. Humans are modelled
individually, with their own male and female worm bur-
den. The concentration of mf in the peripheral blood is
modelled for each individual deterministically and in-
creases according to the number of fertile female worms
as well as decreasing at constant rate. The total mf dens-
ity in the population contributes towards the current
density of L3 larvae in the human-biting mosquito popu-
lation, where the distribution of L3 amongst the human-
biting mosquito population is completely homogeneous.
An empirically derived relationship is used for the
uptake of mf by a mosquito, where both Culex and
Anopheles uptake curves are implemented depending on
setting. The model dynamics are therefore divided into
the individual human dynamics, including age and turn-
over; worm dynamics inside the host; microfilariae dy-
namics inside the host and larvae dynamics inside the
mosquito.
MDA intervention
The effect of MDA was simulated for an individual by
reducing their mf load and worm numbers according to
estimated drug efficacies from the literature (See Table 1
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for a summary of these efficacies and the corresponding
references). After the MDA intervention the dynamics
continue as normal and there is no lasting effects of
MDA except for the initial reduction in mf and worm
number.
Simulation outputs
In order to compare simulations to data a number of
key epidemic statistics were defined using the outputs
from a simulation. The probability that an individual is
mf positive is given as the Poisson probability of a posi-
tive number of mf being detected with rate taken as the
individual’s current mf load. The ICT prevalence was
calculated by averaging over all individuals who have a
positive number of worms. The mf intensity distribution
was calculated using the mf load values for each individ-
ual at a given time-point.
Endemic prevalence
The model parameters that were varied according to the
setting were the aggregation of bite exposure and the
vector to host ratio. The endemic prevalence of mf is
affected by both of these setting parameters (Fig. 1).
Table 1 Summary of parameter values used to inform the model
Parameter symbol Definition Value Source
n Size of population in simulation 1000 unless otherwise stated N/A
λ Number of bites per mosquito 10 per month [37, 38]
V/H Ratio of number of vectors to hosts Fitted to data N/A
αmax Age at which exposure to mosquitoes reaches its maximum level 20.0 [12]
ψ1 Proportion of L3 leaving mosquito per bite 0.414 [39]
ψ2 Proportion of L3 leaving mosquito that enter host 0.32 [40]
s2 Proportion of L3 entering host that develop into adult worms 0.00275 [7, 41]
μ Death rate of adult worms 0.0104 per month [42]
α Production rate of Mf per worm 0.2 per month [39]
γ Death rate of Mf 0.1 per month [39, 43]
ɡ Proportion of mosquitoes which pick up infection when biting
an infected host
0.37 [45]
σ Death rate of mosquitoes 5 per month [40]
k Aggregation parameter of individual exposure to mosquitoes Fitted to data [23, 24]
h(a) Parameter to adjust rate at which individuals of age α are bitten Linear from 0 to 10, with
maximum of 1
[7]
χ1 Proportion of Mf killed for an individual MDA round using
ALB & DEC
0.95 [46, 47]
κ1 Proportion of adult worm permanently sterlised during MDA
round using ALB & DEC
0.55 [46, 47]
ρ Systematic adherence of MDA Varied N/A
pC Coverage of MDA Varied N/A
pN Coverage of LLIN Varied N/A
ρBC Correlation between bite exposure and adherence to MDA Varied N/A
ρCN Correlation between adherence to MDA & LLIN Varied N/A
Fig. 1 Prevalence to vector-host ratio relationships. The endemic
prevalence for a range of vector to host ratios at various population
heterogeneity levels, k. Threshold behaviour is more pronounced
when the population is less aggregated. When the population is
more aggregated, there is little threshold behaviour. With the lowest
k, corresponding with the highest level of aggregation, there is a
smooth transition from zero prevalence to a positive prevalence
within the population
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There is a threshold behaviour where the endemic
prevalence increases sharply from zero as the vector to
host ratio increases. This threshold is highly dependent
on the aggregation of the bite risk within the population
controlled by the parameter k. A smaller k (more aggre-
gated population) leads to a non-zero endemic equilib-
rium at lower vector to host ratios than are observed
when the bite-rate is more homogeneous. This is a con-
sequence of when the bite risk is more aggregated, there
are individuals who are more highly burdened that drive
the infection above the breakpoint threshold. When the
population is more aggregated the endemic prevalence
can occur at lower levels than when the population is
more homogeneous.
Data
The model was fitted and validated against two studies
of an MDA programme over a number of years. The
first is a study of two rounds of MDA using DEC com-
bined with ALB across four sentinel communities in
Malindi, Kenya in the years 2002–2004 [15]. Baseline
blood samples were taken in all four communities before
the first round of MDA in February 2002. Thereafter,
blood samples were taken in March 2003 (post-MDA1)
and July 2004 (post-MDA2). Both the immune-
chromatographic antigen (ICT) and mf tests were
performed on the same blood samples to provide an es-
timate for the prevalence of antigenaemia and microfi-
laraemia in the population. In order to retain statistical
power, the results from the four communities were ag-
gregated to provide a total number sampled in each sur-
vey of n = 808.
Further model fitting was performed on a 2-year study
in the districts of Colombo and Gampaha in Western Sri
Lanka during an MDA programme [16]. This represents
a contrasting dataset as the dominant vector species is
Culex, but where the main drug combination used in
MDA is still ALB and DEC. Antigenaemia was measured
through ICT and microfilaraemia measured through
membrane filtration. Measurements were taken after an
MDA round in August 2004 and just prior to another
MDA round in late July 2005.
Model fitting & comparison
The model was fitted using a maximum likelihood
framework. The expected age-prevalence profile was
calculated for a set of parameters by averaging across
1000 simulation runs. A likelihood was then con-
structed assuming binomial sample error for the num-
ber of individuals testing positive in each age category
of the total population of individuals surveyed. For the
Kenyan dataset, the initial time-point was at baseline
before intervention. The age-prevalence curve was
recorded from the model after reaching endemic
equilibrium and used in the model fitting. For the Sri
Lankan dataset, the initial time-point used in the model
fitting was after the first round of MDA. In order to
perform fitting on this dataset, the simulation was run
until equilibrium at which point an initial MDA round
was simulated. The age-prevalence profile was then
taken 2 months after the initial round and used to com-
pute the likelihood.
The fitted simulation was then compared to the subse-
quent time-points in each dataset for both the mf and
ICT prevalence. MDA was simulated for coverage taken
from the data with efficacy taken from literature esti-
mates. Alongside this the mf intensity distribution was
also compared at baseline for the Kenyan dataset. This
was not done for the Sri Lankan dataset as no baseline
measurements were taken and the number of non-zero
mf counts were too few.
Scenarios
A number of scenarios are considered that can
impact the effectiveness and timeline of a MDA
programme. These are where systematic adherence
of MDA occurs where individuals either consistently
adhere or not adhere to the programme; where
correlation exists between bite risk exposure and ad-
herence; where different forms of vector controls
occur alongside an MDA programme; and where
correlation exists between the MDA and vector con-
trol programme (Table 1 provides a summary of the
parameters used in these scenarios).
Five distinct intervention strategies were compared for
the elimination of LF. These were mass drug administra-
tion at 65 % coverage, mass drug administration at a
higher 80 % coverage, bi-annual MDA at 65 % coverage,
annual MDA at 80 % coverage with use of LLINs for
Anopheles and reduction of bite-rate by 50 % in Culex
areas. These were compared in high, medium and low
transmission settings. Table 2 provides a full list of the
assumptions used in each scenario.
Table 2 Baseline intervention assumptions
Scenario Species
Coverage
(%)
Frequency
(months)
Bite
rate (%)
LLIN
coverage (%)
1 Anopheles 65 12 100 0
Culex 65 12 100 0
2 Anopheles 80 12 100 0
Culex 65 12 100 0
3 Anopheles 65 6 100 0
Culex 65 6 100 0
4 Anopheles 65 12 100 65
Culex 65 12 50 0
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Systematic adherance
Population adherence has been identified as a key factor
associated with the success of an MDA programme [17].
If adherence is systematic then there are a certain group
of individuals who are more or less likely to adhere to
an intervention compared to the average. This could
lead to individuals with higher burden not being treated
due to geographic or planning factors, which can have
negative consequences for reaching elimination. System-
atic adherence is modelled explicitly, allowing a range of
scenarios to be explored where semi-systematic adher-
ence is present [18]. The systematic adherence param-
eter ρ controls the correlation in adherence between
MDA rounds. When ρ = 0, MDA is randomly assigned
to individuals. When ρ = 1, an individual either always
adheres to the intervention or never adheres. For values
in between zero and one a proportion of individuals ad-
heres randomly, whilst a person’s decision to adhere or
not remains the same for each round. Details of the im-
plementation are given in the Additional files.
Correlation between systematic adherence and
exposure risk
We also explore scenarios under which there may be a
correlation between the bite-risk for an individual and
the individual’s tendency to adhere or not adhere with a
treatment. There can be both a positive-correlation,
where the higher bite-risk is associated with a higher
tendency to not adhere with mass drug administration
or a negative correlation, where a higher bite-risk in-
creases the likelihood of adhering with mass drug
administration.
Vector control
One of the established forms of vector control (VC)
considered for filariasis is the use of Long-lasting
insecticide-treated nets (LLINs). LLINs are considered
for vector control in Anopheles settings and we adopt a
similar modelling approach as in [19, 20]. Vector control
increases the time between biting events and as a conse-
quence decreases the bite rate as well as increasing the
mortality. This change in the bite rate and mortality was
modelled using the schematic in Fig. 2, where a mosquito
attempting to feed where a bed net is present either
repeats with probability rN, dies with probability dN or is
successful with probability sN.
The modified global bite rate based on coverage of
bed nets (pN) is the original bite rate (λ) multiplied by a
factor that determines a random bite being successful,
λ(pNsN + (1 ‐ pN)).
The increase in mortality is similarly calculated,
however the mortality under intervention is the natural
mortality (σ) added to the mortality probability due to
the vector control (dN) and so is σ + λpNdN. It is
assumed these effects are constant throughout the whole
time the intervention is taking place.
An individual’s bite-rate is also affected based on
their use of bed nets. This is calculated by reducing
their bite-rate by a factor depending on whether the
bite is successful due to the presence of LLIN. This is
given by λsN if the individual uses a bed net and λ
otherwise (Table 3 provides a summary of these
parameters including references). We conservatively
assume coverage of bed-nets of 50 % when VC is
present and do not include degradation effects of the
nets or sporadic use.
Vector control in a Culex setting was also modelled.
Due to differences in feeding behaviour, other forms of
vector control need to be considered. Polystyrene beads
are used to cover pit latrines and other breeding sites for
Cx. quinquefasciatus and have produced a large reduc-
tion in the annual bite-rate depending on the number of
breeding sites that are covered [21]. We conservatively
estimate a bite-rate reduction of 50 % when a Culex
vector control programme is implemented. Although
much higher reduction in bite rates have been observed
(98 % [22]), the reduced reduction in bite rate was chosen
to encompass a wider range of scenarios where VC may
not be able to effectively cover all breeding sites.
Results
Fitting
The model was fitted to the Malindi, Kenya dataset
using the maximum likelihood fitting procedure. The
fitted parameters were the vector to human ratio V: H
and the shape parameter corresponding to the heterogen-
eity of exposure risk among individuals, k. The maximum
likelihood parameters were estimated to be V: H = 120
and k = 0.08.
As a further step to compare the model fit to the data,
the distribution of mf between individuals was compared
between the recorded mf count data and the predicted
distribution by the model (Fig. 3c). The distributions were
compared for similarity using the Kolmogorov-Smirnov
test statistic, which compares the maximum deviance be-
tween two empirically-derived cumulative distribution
functions and is not rejected under standard hypothesis
testing if the two distributions are statistically similar. This
was performed by sub-sampling without replacement
from the model distribution for the same number of
individuals as in the data (n = 740). For 91 out of 100 re-
samplings the Kolmogorov-Smirnov test statistic returned
a p-value greater than 0.01 confirming that the two sam-
ples are drawn from the same underlying distribution. A
visual comparison of the two distributions also confirms
the similarity between the two distributions.
For further validation, the estimates of the ICT preva-
lence from the simulated MDA campaign were also
Irvine et al. Parasites & Vectors  (2015) 8:547 Page 5 of 19
compared to the data (Fig. 3d). The antigen prevalence
is consistently under-estimated by the model for each
year, although the decline in ICT is comparable to the
decline observed, suggesting that the current model for
ICT prevalence needs further validation.
The fitting was also performed on the Sri Lankan data-
set. Here the initial survey was taken while the area had
already undergone MDA for a year. The parameters
were once again fitted using maximum likelihood. The
fitted parameters were found for vector to human ratio
to be V: H = 55 and the population bite-risk aggregation
k = 0.06. The resulting simulated age-prevalence profiles
match reasonably well with the data and fall within the
confidence intervals of all points, except for the first two
age groups (Fig. 4a). The fit was then compared against
the point-prevalence taken the following year after
another round of MDA. The MDA programme was
simulated with the same coverage and drug combination
as in the survey. The simulations also match closely with
the model for the following year (Fig. 4b).
The ICT prevalence was calculated from the number
of individuals in a simulation at a single time-point with
adult worms present (Fig. 4c). There is close agreement
between the ICT prevalence simulated and the estimate
in the data for both years with both estimates falling
within the 95 % confidence intervals.
Scenarios
Having fitted and compared the model against these
contrasting datasets we now investigate the impact of
different combinations of intervention strategies for a
baseline case, for a scenario in which the heterogen-
eity of worms amongst people is much lower and for
a scenario in which systematic non-adherence is
considered.
Baseline controls
The five intervention strategies were compared assum-
ing completely random coverage of MDA and vector
control. We first present some example simulations of
the averaged ICT prevalence over 200 simulations runs
for a 20 year period from the start of intervention in a
medium endemic setting (Fig. 5a, b). For the Anopheles
setting (Fig. 5a) there is a steady decline for annual
MDA, whereas more dramatic declines are observed for
annual high coverage MDA, bi-annual MDA and MDA
with VC. After 5 years, both bi-annual and MDA with
VC do not increase as transmission has been broken in
all runs. Annual MDA and annual high coverage MDA
bounce back to a lower endemic level as some runs have
achieved elimination whereas others have not. In the
Culex setting, similar observations were made for the
first 5 years of intervention (Fig. 5b). As these timelines
are averaged of different runs, where some achieve elim-
ination and others do not, the bounce back after 5 years
is from those runs that have not achieved elimination.
The probability of a run achieving elimination given that
it fell below the 1 % threshold after 5 years was found to
be one in all settings (not shown in figure).
To compare across scenarios we summarise the behav-
iour after 5 years of intervenions. Figure 5c & d show
the antigen prevalence after 5 years of intervention for
the scenarios in Anopheles & Culex settings respectively.
In low transmission settings, greater reductions can be
seen. For example in Anopheles settings (Fig. 5c) preva-
lence is below two percent (shown as a black dashed
line) in all scenarios. The high endemic setting scenario
provides the greatest contrast as bi-annual treatment
and annual MDA with VC fall below 2 % and annual
Table 3 Summary of vector control parameters for Anopheles
gambiae s.s
Parameter Value Description Reference
rN 0.56 Repeating probability for LLINs [48–50]
sN 0.03 Successful feeding with LLINs [48–50]
dN 0.41 Insecticide mortality probability for LLINs [48–50]
Fig. 2 Schematic of mosquito interaction with LLINs. The diagram represents the interaction between the mosquito vector and LLINs, where
there are three outcomes of biting event: repeating rN, death dN or success sN
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a b
c d
Fig. 3 Fit and comparison of individual-based model to Malindi, Kenya dataset. The model was fitted using maximum likelihood to the baseline
data in 2002. The MDA programme was modelled for the subsequent years and compared to the outcome from the data. a Baseline age prevalence
data used in model fitting given as point estimates with standard errors. Example age prevalence curves from simulations shown in grey. b The range
of prevalence from simulations are given as box-plots with the prevalence from the data given as a single point. c Comparison between
model predicted mf-intensity distribution and mf-intensity distribution derived from data. Data colour is semi-transparent to show model
distribution behind. d The range of prevalence from simulations are given as box-plots with the ICT prevalence from the data given as a
single point
a
c
b
Fig. 4 Fit and comparison of individual-based model to Sri Lanka dataset. a Age prevalence data used in model fitting given as point estimates
with standard errors. Example age prevalence curves from simulations shown in grey. b The range of prevalence from simulations are given as
box-plots with the prevalence from the data given as a single point. c The range of ICT prevalence from simulations given as box-plots with the
prevalence from the data given as a single point
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and annual high coverage MDA are above. In the
medium transmission setting, only annaul MDA is above
the threshold value. In the Culex setting, the ICT preva-
lence is only above the 2 % threshold for annual MDA
in the high endemic setting (Fig. 5d), all the other sce-
narios are above the threshold after 5 years. Very similar
observations are made for the mf prevalence (Fig. 5e, f )
however they are noticeably reduced from the ICT.
Finally the probability of elimination is given for all
scenarios in both the Anopheles & Culex setting (Fig. 5g, f).
This shows the large discrepancy in outcomes of the sce-
narios in different endemic settings. For Anopheles (Fig. 5g)
yearly MDA with VC is capable of achieving elimination in
all settings, albeit at a slightly lower probability for
the highest endemicity. The other interventions show
a range of outcomes, with bi-annual MDA achieving
a b
c d
e f
g h
Fig. 5 Comparison of main strategies for elimination in different settings. These are mass drug administration at 65 % coverage, mass
drug administration at a higher 80 % coverage, bi-annual MDA at 65 % coverage and annual MDA at 80 % coverage. The three endemic
settings considered are mf prevalence 15 % (high), 10 % (medium) & 5 % (low). The left column is in a setting where Anopheles dominates transmission
and the right column is where Culex dominates transmission. a & b are the ICT prevalence for medium endemicity over 20 years averaged over the
simulation runs. c & d are mf prevalence after 5 years; (e) & (f) are ICT prevalence after 5 years and (g) & (h) are the probability of elimination are
5 years
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elimination in low, medium and high settings. Annual
high coverage of MDA can achieve elimination in low
and medium transmission settings for 100 and 85 %
of cases, but only 18 % in high transmission settings.
Annual MDA only reliably leads to elimination in
5 years in the low endemic setting. In the Culex set-
tings, the probability of elimination (Fig. 5h) is high
in a low, medium and high transmission settings for
bi-annual and MDA with VC. Annual high MDA
achieves elimination in over 80 % of cases for low
and medium settings, but less than half for high. An-
nual MDA is the worst performing, with 60, 43 and
9 % probability of elimination in low, medium and
high settings.
Heterogeneity of bite risk
Heterogeneity of bite risk amongst individuals, resulting
in aggregation or clustering of worms within particular
individuals, can vary between regions. In a less heteroge-
neous population interventions can be much more ef-
fective because the density of infective vectors necessary
to sustain transmission is increased [23, 24]. This level
of aggregation or clustering is different in different set-
ting and can only be measured using the mf-intensity
distribution. We investigated whether this variation was
important by simulated the same scenarios as above, but
for a much less clustered or aggregated worm popula-
tion, but where the prevalence was matched to the base-
line scenarios (5, 10 and 15 % mf prevalence). It is
important to note that to achieve the same prevalence
for a more homogeneous population the vector to hu-
man ratio will be lower, making control more achievable.
The resulting scenarios show a large difference in the
outcome of interventions (Fig. 6). Figure 6a & b show
the dramatic decrease in ICT prevalence for 20 years
since the beginning of intervention. After 5 years trans-
mission has been broken for all scenarios, with the more
intensive scenarios such as bi-annual MDA achieving
elimination before the 5 year target. Annual MDA also
continues to decline after 5 years, although it’s reduction
is slower than other scenarios only reducing the preva-
lence to near zero after 10 years. Both the ICT preva-
lence (Fig. 6c, d) and the mf prevalence (Fig. 6e, f ) after
5 years indicate that all interventions have effectively
broken transmission. This is confirmed by the probabil-
ity of elimination for Anopheles and Culex (Fig. 6g, h)
where there is 100 % elimination in all scenarios. The
exception is with annual MDA in a Culex setting
(Fig. 6h), however the probability is still above 80 % for
all endemic settings.
Adherence of intervention
Another important factor which can affect the success of
a programme, and an assumption which can have a large
impact on model predictions, is the extent of systematic
non-adherence in the population, and whether this is
correlated with other factors. In the supplementary in-
formation we investigate these effects more extensively,
but we summarise the results through the scenario ana-
lyses. The scenarios were investigated where on average
50 % of the population systematically complies with
MDA. We also simulate a correlation coefficient of 0.5
between adherence with MDA and adherence with bed
nets (reflecting a setting where access to all health care
interventions is easier for some in the population than
for others) and the same for bite risk and MDA (reflect-
ing a scenario in which poor access to interventions is
particularly acute for the high risk group). There is little
information available on the realism, or otherwise, of
this type of scenario, but we include it to illustrate the
potential importance of these types of effects on the effi-
cacy of a control programme. The results show that the
effectiveness of these interventions can be undermined
when these type of issues exist (Fig. 7). MDA with vector
control is still likely to be able to achieve elimination in
all cases for low and medium endemicity, but not in the
high setting, whereas this was the case for the baseline
scenario. The bi-annual intervention all suffered from a
greatly reduced probability of elimination, declining
from 100 to 65 %, Annual MDA at high coverage was
able to achieve elimination 60 % of the time, with annual
MDA only 14 %. The outcome for medium endemicity
is also worsened, with most strategies ineffective at
achieving elimination above 50 % with the exception of
when vector control is included (Fig. 7g). In Culex set-
tings the interventions in the face of these complications
fare relatively similarly with a decline in elimination for
all strategies and nearly no chance of elimination for
annual MDA alone (Fig. 7h).
In order to investigate the impact of these types of
correlations further, we look across a range of parameter
values. When a higher bite exposure is associated with a
tendency to not adhere to intervention decreases the
success of an MDA programme, when a correlation ex-
ists between higher bite exposure and adherence, the
probability of elimination can be dramatically increased.
For example, annual MDA at 80 % coverage with high
endemicity can increase the elimination probability from
2 to 48 % (Fig. 8a).
Correlation between MDA and LLIN adherence can
also limit the success of an elimination campaign. For a
moderate amount of systematic adherence and non-
adherence (ρ = 0.75), a correlation between individuals
who use LLIN and receive MDA treatment can dramatic-
ally decrease the probability of elimination. For example,
with LLIN coverage of 65 %, a correlation can decrease
the probability of elimination within 5 years from 80 to
30 % (Fig. 8b).
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Discussion
Elimination of lymphatic filariasis through the use of
mass drug administration is a potentially complex prob-
lem with many open questions and challenges necessary
to tackle as coverage increases globally. Nevertheless,
the global programme has been very successful in a
number of countries. However, where the programme is
less successful it is difficult to disentangle the reasons
for this failure, which may be multi-factorial. We have
developed a novel model of filariasis infection amongst
individuals with the primary aim of comparing strategies
in terms of their likely impact on achieving elimination.
The model builds upon two established models of LF in-
fection, EPIFIL and LYMFASIM [7, 8]. It is able to re-
produce aggregated infections observed across two
settings as well as reproduce expected declines in both
prevalence of mf and ICT. This new tool allows the
comparison of a variety of intervention strategies used in
a b
c d
e f
g h
Fig. 6 Comparison of main strategies for elimination of LF in different settings with a more homogeneous distribution of risk. These are mass
drug administration at 65 % coverage, mass drug administration at a higher 80 % coverage, bi-annual MDA at 65 % coverage and annual MDA at
80 % coverage. The three endemic settings considered are mf prevalence 15 % (high), 10 % (medium) & 5 % (low). The left column is in a setting
where Anopheles dominates transmission and the right column is where Culex dominates transmission. a & b are the ICT prevalence for medium
endemicity over 20 years averaged over the simulation runs (c) & (d) are mf prevalence after 5 years; (e) & (f) are ICT prevalence after 5 years and
(g) & (h) are the probability of elimination are 5 years
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combating filariasis, as well as giving the ability to model
further complications in human behaviour and vector
biology. We have compared these strategies with the
aforementioned complications in order to provide robust
estimates of the probability of elimination. The novelty
of this analysis is the comparison of the model against
longitudinal surveillance data from two quite different
sites, in Kenya and Sri Lanka. The use of this longitudinal
data gives confidence in the model’s predictions for mf
prevalence, but highlights some remaining issues in terms
of the simulation of ICT prevalence, the main tool for sur-
veillance in recent years.
a b
c d
e f
g h
Fig. 7 Comparison of main strategies for elimination of LF in different settings, with systematic adherence included. The interventions compared
are mass drug administration at 65 % coverage, mass drug administration at a higher 80 % coverage, bi- annual MDA at 65 % coverage and
annual MDA at 80 % coverage. The three endemic settings considered are mf prevalence 15 % (high), 10 % (medium) & 5 % (low). Furthermore,
there is a 50 % correlation between whether an individual complies with the intervention in each round, combined with a correlation of 0.5
between bite exposure and MDA adherence as well as a 0.5 correlation between use of bed nets and adherence with MDA. The left column is in
a setting where Anopheles dominates transmission and the right column is where Culex dominates transmission. a & b are the ICT prevalence for
the medium endemic setting over 20 years averaged over the simulation runs; (c) & (d) are mf prevalence after 5 years; (e) & (f) are ICT
prevalence after 5 years and (g) & (h) are the probability of elimination are 5 years
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Simulations of the model suggest that MDA alone may
result in elimination in many settings if coverage is suffi-
cient or if a bi-annual treatment strategy is adopted. The
timeline to elimination is broad and elimination within 5
years may only be possible when MDA is combined with
vector control in certain high endemic settings. The sim-
ulations also suggest that when overall prevalence is
below 2 % for mf and 1 % for ICT, recrudescence is un-
likely to occur, although a formal analysis of this was not
conducted here. Bi-annual MDA represents a significant
increase in the resources and logistics required in order
to achieve similar coverage with annual MDA [5].
Therefore, if annual intervention at higher coverage is
able to achieve elimination rather than switching to bi-
annual coverage, the former would be preferred. There
may be an issue that annual MDA is not sufficient to
break transmission and the prevalence will continuously
bounce back between interventions. With such a case
elimination may never be feasible within a reasonable
timeline. Where the main vector of transmission is
Anopheles annual MDA at 95 % coverage has similar
outcomes to bi-annual coverage at 65 %. For a popula-
tion of 1000, this means there are 350 fewer individual
treatments required each year, along with significantly
less resources and personnel cost. There is therefore
evidence that increasing the coverage of an annual
programme rather than switching to twice yearly would
have the same results at reduced costs, which supports
previous analysis [5]. A higher coverage however does
represent a significant scaling up in terms of logistics
and resources, for instance high coverage has been
achieved for example in Sierra Leone during National
Immunisation Days [25]. Accurate mapping combined
with modelling can be an important tool in order to as-
sess whether such a scale up of coverage is required.
One open challenge facing the estimates of elimination
is knowledge of how heterogeneous the number of bites
per individual is in a population where LF is endemic. A
less heterogeneous bite risk means that an individual’s
bite rate deviates little from the mean and hence epi-
demiological differences are fewer. This has a profound
effect on an MDA programme as less difference between
individuals means that random coverage of treatments is
able to achieve elimination sooner [23, 24]. If the popu-
lation is more heterogeneous then some individuals may
have comparatively much higher worm burdens and mf
compared to the average. This has two impacts: one is
that the overall prevalence appears low as a dispropor-
tionate amount of burden is in a smaller number of the
population and a random coverage of MDA is less ef-
fective as it may not cover those individuals who have
high burden. Having better estimates of this heterogen-
eity, through mf count or other proxy data, and better
mechanistic understanding in the origin of the hetero-
geneity of risk, whether through behaviour, immunity or
other factors will allow us to improve failing pro-
grammes, survey for recrudescence and more accurately
estimate breakpoints [26, 27]. On a short term, practical
level, the use of individual data on mf, which was rou-
tinely collected in surveillance, but rarely utilised, means
that models can make much more effective predictions
on the impact of MDA, as illustrated in the model fitting
and validation above.
The use of vector control alongside an established
MDA programme has been shown to be an effective
strategy in breaking transmission in high endemic areas
[28]. Our results confirm this observation and suggest
that fairly moderate coverages of bed-nets can lead to a
dramatic decrease in the time to reach elimination.
There is also the indication that vector control alone
may be enough to achieve elimination in a low endemic
setting. For example in the Gambia, elimination targets
were achieved through the use of insecticide-treated
bed-nets distributed for a malaria campaign, where there
a b
Fig. 8 Impact of systematic correlations on MDA campaign. Correlation between adherence to MDA and other factors can negatively impact an
elimination campaign. Probability of elimination after 5 years for an annual MDA programme at various MDA coverages (pC) and LLIN coverages
(pN), where there is either (a) a negative to positive correlation with bite-risk and non-adherence to MDA or (b) a positive correlation between
LLIN and MDA non-adherence
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was no other LF intervention [29]. Similar observations
were made in Kenya, where mf prevalence continued to
decline despite missed rounds of MDA [30]. Use of bed-
nets also increases the chances of elimination even after
MDA has ceased [31]. We also demonstrate that the use
of general vector control that target breeding sites in a
Culex setting can also help to achieve elimination within
5 years. In these areas where malaria is co-endemic,
bed-net use may be higher than the 50 % we conserva-
tively used in our scenarios. This demonstrates the
necessity to model the use of VC in order to provide
more accurate estimates of elimination and also explore
other mechanisms that might lead to a change in the
vector dynamics such as the use of ivermectin [32].
Human behaviour and selective coverage can both
have a large impact towards an elimination campaign
[17, 33, 34]. We explored a number of different scenar-
ios in which correlation between interventions and ex-
posure lead to negative consequences for an elimination
timeline. Systematic adherence was controlled for by set-
ting the correlation between treatment rounds, where a
higher correlation means an individual is more likely to
choose their previous decision on whether to receive
treatment. This allowed both systematic adherence as
well as coverage to be altered independently in order to
measure the effects of both. Systematic adherence alone
has a marginal impact on the probability of elimination.
However when other correlations were considered, the
impact was much greater. A correlation between expos-
ure to infective bites and non-adherence can in some
cases lead to no chance of elimination where it could be
achieved at high levels when this was not the case.
Correlation between insecticide-treated bed-nets (LLINs)
non-adherence and MDA non-adherence can also dra-
matically reduce probability of elimination. The other
aspect to this is where MDA is more targeted towards
individuals with a higher exposure. This is where indi-
viduals more highly burdened are more likely to receive
treatment perhaps due to greater awareness of the dis-
ease. This can lead to a large increase in the probability
of elimination. An open question is how much this
correlation exists and how much it may vary between
settings. Practical tools for measuring these effects
would be useful for evaluating control programmes that
are failing to reach their targets.
Estimation of prevalence through the use of an
immuno-chromatographic card test (ICT) has rapidly
become the more popular method of estimating preva-
lence compared to measuring mf in the peripheral blood
due to its cheaper cost, easier implementation and rela-
tively little training to perform [35]. Open questions re-
main in how to relate the ICT prevalence to the mf
prevalence however, due to ICT measuring an antigen
secreted from adult worms as opposed to measuring
adult worms directly [36]. Here, we improve on previous
modelling work by using the presence of adult worms in
an individual as an indicator of a positive ICT and hence
measuring the antigen prevalence for given scenarios.
Although validation between the simulated and esti-
mated ICT was strong in the Sri Lanka fit, it was less so
in the Kenyan fit, where the ICT was consistently under-
estimated. Possible reasons for this may be due to a sub-
set of the population being infected with infertile worms
that would show up under ICT and not an mf test or
that antigens in the blood may remain after adult worm
mortality and so ICT-positives can remain in the popula-
tion even after transmission has been broken. The sensi-
tivity and specificity of ICT and mf tests are different
and this will also impact the discrepancy. Other possible
mechanisms for the discrepancy between antigenaemia
and microfilaraemia are due to decreasing fecundity
alongside increasing heterogeneity of adult worms
during an MDA campaign (Irvine M, et al. Understand-
ing the relationship between population level prevalence
of microfilariae and antigenaemia using a model of
lymphatic filariasis infection, submitted). These scenar-
ios may be modelled in the current framework in order
to better estimate the relationship and provide answers for
this pressing issue.
Data & programmatic implications
The modelling work has identified a number of key
areas that are important to address with regards to an
elimination prgramme. In a timeline of 5 years bi-annual
MDA at 65 % is the most effective of all strategies con-
sidered. However, if bi-annual MDA is not feasible, then
an MDA programme combined with vector control can
also have a similarly high probability of success in all set-
tings. Annual MDA at 80 % with no VC is only effective
in low and medium settings and annual MDA at 65 % is
only effective for lower endemic settings. A number of
systematic adherence issues can impact the success of a
programme such as individuals who don’t adhere having
higher burden, use of LLINs being correlated with ad-
herence to MDA for an individual and systematic com-
pliance to MDA. Where there are units that have not
met goals within a specified timeline these would be the
main sources to investigate.
How exposure is distributed among individuals due
to proximity to breeding sites etc. also has large im-
plications for the success of a programme. A proxy of
this can be taken from understanding the distribution
of intensity of infection. Therefore using mf or anti-
gen count data, which is already collected, should be
used to inform modelling work and threshold targets
for prevalence.
Differences between Anopheles & Culex uptake curves
also have important implications for elimination. Big
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differences in competence have also been observed for
closely related species. Data on vector competence, be-
haviour, ecology and species distributions would allow
for more accurate modelling work and aide in elimin-
ation strategies.
Conclusion
We have considered the question of whether mass drug
administration alone is capable of achieving elimination
within the ambitious 2020 goals. To this end we devel-
oped a novel model of filariasis infection where an indi-
vidual’s treatment, use of vector control and ability to
adhere or not to interventions may be explicitly mod-
elled. We have found that in most settings elimination
may be achieved if the intervention is intensive enough.
For areas with higher endemicity, this ambitious goal
may not be achieved and other forms of intervention
would need to be considered, principally higher coverage
of both MDA and possibly additional vector control. We
identified a number of issues that may inhibit an elimin-
ation campaign however. Chiefly, the aggregation of bite
risk amongst a population can limit the reduction in
prevalence due to MDA. Systematic adherence when
coupled with exposure and adherence to other inter-
ventions can also have a large negative impact on a
campaign. There is therefore a need to produce more
accurate estimates of population aggregation by fully
utilising individual-based data in models for elimination.
Additional files
Model
We introduce a novel model of filariasis transmission.
The model is a stochastic micro-simulation of individ-
uals with worm burden, microfilaraemia and other
demographic parameters relating to age and risk of ex-
posure. Humans are modelled individually, with their
own male and female worm burden denoted Wi
m and
Wi
f. The density of mf in the peripheral blood is also
modelled for each individual and denoted Mi. The total
mf density in the population contributes towards the
current density of L3 larvae in the human-biting
mosquito population. The model dynamics are divided
into the individual human dynamics, including age and
turnover; worm dynamics inside the host; microfilariae
dynamics inside the host and larvae dynamics inside the
mosquito.
Worm dynamics
For each individual i both male and female worms are
added according to their bite risk bi that is individually
drawn from a gamma distribution with mean 1 and
shape parameter k (this means that the scale parameter
is automatically determined to keep the mean of the dis-
tribution at one, hence θ = k−1). The rate at which
worms are acquired depends on a number of stages of
larvae life cycle as well as characteristics of the host.
These are the mean total number of bites per individual
per month b; the number of bites per mosquito λ; the
ratio of vectors to hosts V: H; the probability that an L3
larvae leaves the host during a biting event ψ1; the prob-
ability that the L3 enters the host ψ2; the proportion of
L3 within the host that develop into adult worms s2; and
the age-dependent biting rate h(a) that increases with
body size to saturate at age nine [7]. The rate at which
an individual i acquires an adult worm is therefore
1
2
λbi V : Hð Þψ1ψ2h að Þ;
for both male and female worms. All the parameters
described can be derived from literature estimates with
the exception of the bite-risk shape parameter k and the
vector to host ratio V:H . Therefore both of these pa-
rameters need to be fitted for each setting. Each worm
has a constant rate of death μ, which is the same for
males and females. Therefore the number of deaths in a
time-step is Poisson-distributed with rate μWi
m and
μWi
f for male and female worms respectively.
Mf dynamics
The microfilariae dynamics are dependent on the total
number of adult male and female worms. W. bancrofti is
assumed to be completely polygamous [12] and hence the
rate at which mf are produced is dependent upon the num-
ber of female worms combined with the presence of male
worms. It is also assumed that there is death of the micro-
filariae that is constant and independent of the density of
the mf. The dynamics of mf for an individual і are therefore
dMi
dt
¼ αWfi I Wmi > 0
 
‐γMi;
where the function I is one if there are male worms and
zero if not.
Larvae dynamics
The larvae develop from the mf that enter the mosquito
during a blood meal from an infected host. There are
two functional forms of this relationship that differ ac-
cording to mosquito genus. For Culex, where the cibarial
armature is less-developed than in other species, mf can
survive at lower densities [13]. The relationship here is
L mð Þ ¼ κs1 1‐e‐r1m=κs1
 
:
For Anopheles larvae survival and development is facil-
itated at higher densities of mf. This relationship is given
by
L mð Þ ¼ κs2 1‐e‐r2m=κs2
 2
;
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where m here is concentration of mf per 20 μL taken
during a blood meal and r, κ are parameters relating to
the functional form of the uptake curve [14]. Each
individual contributes towards the pool of larvae in the
mosquito population according to their concentration of
mf in the peripheral blood along with their intrinsic
bite-risk bi. The uptake of mf that develop into larvae is
an average of all individual’s mf concentration weighted
by their bite-risk i.e.
~L ¼
X
i
L mið Þbi=
X
i
bi;
giving the average number of larvae per mosquito.
The dynamics of larvae in the mosquito are developed
in very similar vain to EPIFIL [7]. The dynamics are fast
compared with the other aspects of infection due to the
relatively short life-span of mosquitoes compared with
filarial worms. The density is dependent on the number
of bites per mosquito λ, the proportion of mosquitoes
which pick up infection when biting an infected host ɡ;
the death rate of L3, which is dominated by mosquito
death σ1 and the proportion of L3 leaving the mosquito
per bite, ψ1. The average number of larvae taken up in
the mosquito population ~L is calculated from the uptake
curves described above,
dL
dt
¼ λɡ~L‐ σ1 þ λψ1ð ÞL:
Finally the equilibrium value for L3 in a mosquito is
given by
L ¼ λɡ
~L
σ1 þ λψ1
:
Hence the equilibrium value of the larvae is a scaling
of the uptake of mf that develop into larvae.
Host dynamics
Each individual begins with zero infection and a bite-
rate exposure that is drawn from a Gamma-distribution
with mean 1 and shape parameter k. The shape param-
eter defines how aggregated bites are amongst individ-
uals and consequently defines the aggregation of
infection amongst individuals. The human death rate τ
is assumed to be constant throughout an individual’s
lifetime with a cut-off at age 100. This results in a
truncated exponential for the ages of inidividuals in a
simulation.
Coverage and adherence of MDA
Systematic adherence of individuals to mass-drug ad-
ministration was modelled by assigning an individual a
probability of receiving an effective dose during a
treatment round ui drawn from a normal distribution
with mean u0 and variance σ
2,
ui eN u0; σ2 :
During each treatment round an individual is treated
according to whether a randomly assigned variable z is
less than zero. This random variable is drawn from a
normal distribution with mean ui and variance 1.
z eN ui; 1ð Þ:
For there to be a coverage of p, the following must
hold,
p ¼ Φ ‐u0=
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
1þ σ2
p 
;
where Φ is the standard normal cumulative distribution
function. The value for u0 may therefore be calculated
using a pre-defined treatment coverage as
u0 ¼ Φ1ðpÞ
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
1þ σ2
p
:
The amount of systematic adherance is controlled
through the variance σ2, which is defined as
σ2 ¼ ρ
1‐ρ
:
For ρ = 0 the variance is also zero and hence the re-
ceiving treatment is uncorrelated between individuals.
This would be when there is no systematic adherance.
As ρ increases to 1, the variance for an individual’s ran-
dom choice value ui increases meaning it is more likely
to be far above or below zero and hence means that ad-
herence is more strongly correlated for an individual.
This provides a method for changing the amount of sys-
tematic adherence without altering the total treatment
coverage.
We simulated a number of scenarios of intervention
alongside potential complexities which may limit the
effectiveness of the intervention. The initial group of
scenarios studied are for MDA coverage at 65, 80 and
95 % along with systematic adherence levels of 0.0,
where each round of treatment has random coverage
which is not correlated with previous rounds; 0.5, where
an individual’s decision to comply is the same as in the
previous round 50 % of the time and 1.0, where an indi-
vidual either always complies or never complies with
MDA. These scenarios are considered for low, medium
and high endemic settings and for Anophelene and
Culicine dominated regions.
For the annual MDA setting with the Anopheles
vector, coverage rapidly speeds up the time to elimin-
ation in low and medium settings (Additional file 1:
Figure S1). The probability of elimination to reach 50 %
in a low setting reduces from approximately 8 to 5 years
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as coverage increases. The medium setting is more pro-
nounced reducing the time from 15 to 6 years. Annual
MDA alone is not enough to achieve elimination in all
but the highest coverage of MDA, where the time to
achieve elimination in 50 % of runs is approximately
15 years. The effect of systematic adherence generally in-
creases the time to elimination, however, this effect is
relatively small compared with the effect of increased
coverage, increasing the 50 % elimination probability
time by at most 2 years for all cases, except in the
medium endemic setting in low coverage where there is
an increase by 5 years.
For an annual MDA programme in a Culicine region,
annual MDA is ineffective for medium and high en-
demic settings at low to medium coverage (Additional
file 2: Figure S2). For low endemicity, the time to elimin-
ation is dramatically increased compared to an Anophelene
region and the time to elimination is less than a
decade for only the highest coverage. Systematic
adherence again has a marginal effect on the time to
elimination.
Increasing from annual to bi-annual MDA significantly
decreases the time to elimination for low and medium
endemic settings as well as being able to break trans-
mission for the highest endemic level (Additional file 3:
Figure S3). High coverage can reduce the time to elimin-
ation to under 5 years for medium and high coverage, with
systematic adherence only have a marginal effect on the
outcome of the campaign.
Finally for bi-annual MDA in an Anophelene re-
gion, elimination can be achieved within 5 years for
all endemic settings and levels of systematic adher-
ence (Additional file 4: Figure S4). In a low endemic
setting 65 % coverage is enough to achieve elimin-
ation within 5 years, whilst 80 % coverage is re-
quired for a medium setting. To achieve elimination
within 5 years for a high setting, a coverage of 95 %
is required and this is not altered by the presence of
systematic adherence.
Correlation between exposure and tendency to comply
with MDA
The presence of correlation between exposure and ten-
dency to comply with MDA was modelled for various
coverages and strengths of correlation. This was imple-
mented by first constructing a multi-variate normal dis-
tribution with the following covariate matrix
Σ ¼ σ
2 σρBC
σρBC 1
 
;
where ρBC is the correlation between the bite-exposure
and the systematic adherence of an individual and can
vary between −1 and 1. The next step is to construct the
mean of the multivariate normal, defined as
M ¼ u0; 0ð ÞT :
An individual’s tendency to comply with MDA ui and
a standard normal variable representing their bite risk
(b^ i) are drawn from a multivariate normal distribution as
ui; ; b^ i
  eMVN M;Σð Þ:
In order to convert the normal-distributed bite-risk b^ i
into the gamma-distributed bite-risk bi, which is used in
the simulations, the inverse cumulative distribution
function (CDF) of the standard normal is first applied
converting into a uniformly distributed random number.
The inverse of the gamma CDF is then applied to this
random variable, producing a gamma distributed ran-
dom variable that is still correlated with the tendency to
comply or not comply with MDA.
The probability of achieving elimination was explored
if there is a positive, or negative correlation between an
individual’s bite risk and their adherence with an MDA
programme (Additional file 5: Figure S5 & Additional
file 6: Figure S6). MDA was performed bi-annually for 5
years at three coverage levels and four levels of system-
atic adherence from none, weak, strong and very strong.
The correlation greatly affects the outcome of an MDA
programme in a short time-frame and dramatically in-
creases the probability of elimination at low coverage
levels.
In the low endemic setting, coverage of 80 % is enough
to achieve elimination within 5 years with probability
over 90 %, when there is no systematic adherence
(Additional file 5: Figure S5). When adherence is linked
to bite risk there is a severe reduction in probability of
elimination at low and medium coverages. The same
level of reduction is not observed in the highest coverage
with only a marginal decrease of 20 % points in the most
severe case.
For a high endemic setting, a correlation between
bite-risk can decrease or increase the probability of
elimination depending on whether exposure is linked
to adherence or non-adherence. When there is a link
between exposure and adherence, a moderate coverage of
80 % can increase the probability of elimination from 0 to
45 %. A correlation between exposure and non-adherence
by contrast severely reduces the probability of elimination
from over 60 % for high coverage of MDA to less than
10 % (Additional file 6: Figure S6).
Vector control
Vector control was again modelled for low, medium
and high endemic settings defined as average endemic
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prevalence of 10, 15 and 20 %. The individual-based
model of long-lasting insecticide treated bed nets
(LLINs) were modelled for coverages of 65, 80 and
95 %. These were assumed to not be correlated with
the MDA programme, which had coverage of 65 %
with both annual and bi-annual interventions modelled.
The probability of elimination was measured for each
setting, LLIN coverage and annual and bi-annual MDA.
For the annual intervention setting, bed net coverage al-
ters the probability to elimination from the baseline
(Additional file 7: Figure S7). Moderate coverage of 65 %
is enough to achieve 100 % elimination within 5 years in
a low endemic setting, whilst also increasing the prob-
ability in a high endemic setting from zero to 10 %. In-
creasing the bed net coverage to 95 % of the population
also dramatically increases the probability of elimination
with a high coverage of MDA leading the 100 % prob-
ability of elimination in all but the high endemic setting
categories.
The impact of the use of LLINs on a bi-annual
MDA programme is also pronounced (Additional file 8:
Figure S8). For moderate coverage of 65 % along with
moderate coverage of MDA the probability of elimination
is 100, 90 and 20 % for low,medium and high settings
respectively. This is a dramatic increase in the elimin-
ation probability from an annual campaign where
even high bed net coverage is not enough to achieve
significant probability for a moderate coverage of
MDA. For high bi-annual coverage of MDA, elimin-
ation is achieved in all endemic settings. Vector control
combined with a bi-annual elimination programme is
therefore able to eliminate within 5 years for a large range
of endemicity.
Correlation between adherence of MDA and VC
Positive correlation between LLIN and MDA adherence
was considered for different systematic adherence levels
and coverage of LLIN (Additional file 9: Figure S9). A
65 % coverage annual MDA campaign was imple-
mented alongside a bed-net campaign that are distrib-
uted during the first round of MDA. Weak to strong
systematic adherence combined with a correlation
between LLIN and MDA can negatively impact the out-
come of the intervention when coverage of bed nets is
low. This is due to individuals who are treated are also
more likely to use bed-nets and so a larger proportion
of the population receive neither intervention. When
coverage of bed nets is high, elimination occurs in
nearly all cases and so this correlation matters less.
However, when coverage is low and there is a high
probability of not achieving elimination for the same
conditions, the correlation between interventions
can reduce the probability of elimination by as much
as 60 %.
Impact of these correlations on the dynamics
In order to investigate the effect of these different
correlations on the dynamics of an MDA programme,
we consider a range of systematic adherence parame-
ters (ρ = 0.0,0.5,0.99) and a range of coverage levels
(pC = 0.65,0.8,0.95) for high medium and low preva-
lence (10, 15 and 20 % mf prevalence). We compare the
reductions in prevalence 5 years into the programme
probability of elimination for each of these settings, where
elimination is defined as when transmission has been
broken and no bounce back to pre-intervention levels can
occur, even when intervention has been stopped. System-
atic adherence alone has a marginal impact on the out-
come of a MDA programme (Additional file 1: Figure S1,
Additional file 2: Figure S2, Additional file 4: Figure S4,
Additional file 3: Figure S3 Other complications however,
have a larger impact on the effectiveness of an interven-
tion programme.
For annual MDA at 65 %, coverage of 65 % is only able
to achieve elimination after 5 years for a low endemicity
and after 10 years for medium endemicity (Additional
file 1: Figure S1). 65 % is not enough to achieve elimin-
ation in the high endemic setting. Increasing to 80 %
coverage shortens the time to elimination for low and
medium endemicity and is able to achieve elimination in
10 % of cases after 15–20 years of MDA. High coverage
of 95 % rapidly speeds up the time to elimination for
low and medium endemic settings to between 4 and 8
years. The probability of elimination in a high endemic
setting begins to increase around 9 years of MDA and
continues to climb to 60 % after 20 years of annual
MDA.
Calculating the vector to human ratio, prevalence
relationship
In order to simulate a number of diverse scenarios, we
required simulations to have endemic states at a number
of different prevalences. As prevalence is not a free
parameter in the model, this was done by changing the
vector to human ratio V: H. We therefore calculated the
mean prevalence over 200 simulation runs or a range of
vector to human ratios and used the resulting relation-
ship to calculate the required parameter for a given
prevalence value (Additional file 10: Figure S10). The re-
lationship was also calculated for the two main vector
genera Anopheles and Culex. For a large vector to host
ratio there is no significant difference in prevalence,
however a lower ratios there is an appreciable difference,
where Culex has a breakpoint lower than Anopheles. For
a range of values, high, medium and low transmission
settings were required. The prevalences taken were 10,
15 and 20 % with the corresponding V: H estimated by
using the first value for which that prevalence is
achieved. These were estimated as 39, 60 and 120.
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negatively impact the outcome of the intervention. (PDF 246 kb)
Additional file 10: Figure S10. Relationship between vector to host
ratio & prevalence. Calculated relationship between the vector to human
ratio and the mf prevalence for Anopheles & Culex in the model for 200
simulation runs for each point. Variability of the prevalence is displayed
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